An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism

An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism

The use of synthetic organisms could provide opportunities for discovery and advanced manufacturing of medical drugs. Here the authors use a semi-synthetic organism with an expanded genetic code to generate site-specific chemical modifications in human IL-2.

Saved in:
Bibliographic Details
Main Authors: Jerod L. Ptacin, Carolina E. Caffaro, Lina Ma, Kristine M. San Jose Gall, Hans R. Aerni, Nicole V. Acuff, Rob W. Herman, Yelena Pavlova, Michael J. Pena, David B. Chen, Lilia K. Koriazova, Laura K. Shawver, Ingrid B. Joseph, Marcos E. Milla
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Science
Q
Online Access:https://doaj.org/article/1eeb5f339edc4637a3c9f0f0c17dcf95
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/1eeb5f339edc4637a3c9f0f0c17dcf95

Similar Items